October 26, 2012 – Silicon Bayou News

The New Orleans BioInnovation Center announced today that client Wibi+Works, an emerging biotechnology company, received $400,000 to advance stem cell therapy for treating rheumatoid arthritis. The company received the Phase I Small Business Innovation Research (SBIR) grant funding from the National Institutes of Health (NIH). Wibi+Works will use the funding to advance this technology in conjunction with Dr. Gary Firestein and Dr. Monica Guma at the University California San Diego.